BSE filing, NSE: SUNCLAY. Summary written from the filing by ALFA Finder's alert engine.
Sundaram-Clayton Ltd: key numbers
- Share price
- ₹1,149.50
- Market cap
- ₹2,534 Cr
- Revenue (annual)
- ₹2,026 Cr
- Net profit (annual)
- ₹252.4 Cr
- P/E (TTM)
- 10.1×Sector 31.7×
- Promoter holding
- 59.09%+0.00% QoQ
- FII holding
- 0.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sundaram-Clayton Ltd
All →Sundaram-Clayton Q2 FY27 Results: Net Loss of ₹50.8 Cr, Loss Narrows
Sundaram-Clayton Ltd reported revenue from operations of ₹697.7 Cr (+41.0% YoY) and a net loss of ₹50.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹50.8 Cr
Sundaram-Clayton Board Meeting Date
Sundaram-Clayton convenes a board meeting on 4 November 2026 to consider quarterly results. Trading window stays closed until 6 November 2026.
Sundaram-Clayton Other Announcement
Sundaram-Clayton filed its quarterly shareholding pattern for the period ending September 30, 2026, noting the cessation of VEE ESS Trading due to amalgamation.
Sundaram-Clayton Management Change
Mr. P Kaniappan has resigned as an Independent Director of Sundaram-Clayton Limited, effective 13th October 2026, to pursue other interests.
Sundaram-Clayton Other Announcement
Sundaram Clayton Limited's shareholders approved the re-appointment of M/s. Raghavan, Chaudhuri & Narayanan as Statutory Auditors for a five-year term at the 9th AGM.
Sundaram-Clayton Annual General Meeting
Sundaram-Clayton Limited held its 9th Annual General Meeting on 28th July 2026. The meeting transacted business including the adoption of financial statements and re-appointments.
Other results update announcements
All →Redington Results Update
Redington reports Q2 FY27 revenue of ₹43,002 crore, up 48% YoY, with PAT of ₹581 crore. Growth led by India revenue (+67%) and Technology Solutions Group (+91%).
Jyothy Labs Results Update
Jyothy Labs posted Q2 FY27 revenue of ₹760 crore and PAT of ₹10.6 crore. H1 FY27 revenue reached ₹1,533 crore with PAT of ₹58.2 crore amid margin pressure.
Ecoplast Results Update
Ecoplast Q2 FY27 revenue grew 36% to ₹73.93 crore, but PAT fell 67% to ₹0.78 crore. A new greenfield plant became operational in October 2026.
Marksans Pharma Results Update
Marksans Pharma reported Q2FY27 revenue of ₹940 crore and H1FY27 PAT of ₹303 crore. EBITDA grew 48% to a record ₹214 crore in the quarter.
Rajshree Polypack Results Update
Rajshree Polypack reported Q2 FY27 revenue of ₹102.90 Cr, up 19.06% YoY, and PAT of ₹5.02 Cr. Half-year PAT rose 40.87% YoY to ₹12.27 Cr.
Biocon Results Update
Biocon reported Q2FY27 consolidated total income of ₹4,423 crore with EBITDA at ₹865 crore. Net profit was ₹41 crore as Biopharma revenue grew 5% YoY.